Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma
Cancers · 03.08.2026 · 18 (15) · 2487
DOI: 10.3390/cancers18152487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.08.2026. Verfasst von U Sin Wong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of …. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Committee, CUHK Knowledge Transfer Committee-IdeaBooster Fund, Chinese University of Hong Kong.
Abstract (Originalsprache)
Late-stage cutaneous melanoma management has already evolved into systemic therapy thanks to the fast development of novel targeted inhibitors and immune checkpoint blockers. Therefore, a reliable prediction of systemic therapy response became crucial for making a personalised management plan for melanoma patients. Although there are multiple biomarkers already available, the overall predictive confidence remains low due to heterogeneous responses among patients. Therefore, novel solid predictive biomarkers are still greatly needed. With the development of new technologies and artificial intelligence, new predictive models are being proposed and generated. In this review, we thoroughly evaluated the established biomarkers that are already in use for clinical practice. In addition, we proposed the emerging new markers with great potential by critically reviewing the literature. Furthermore, we proposed a future framework for making a tailored clinical management plan for melanoma patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
- Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
ORCID-Profile: Dajiang Guo
Förderung
- University Grants Committee
- CUHK Knowledge Transfer Committee-IdeaBooster Fund
- Chinese University of Hong Kong
- United College Endowment Fund
- Research Grants Council-General Research Fund
- CUHK
- United College Endowment Fund Research
Zitieren
APA
Wong, U. S., & Guo, D. (2026). Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma. Cancers, 18(15), 2487. https://doi.org/10.3390/cancers18152487
Vancouver
Wong US, Guo D. Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma. Cancers. 2026;18(15):2487. doi:10.3390/cancers18152487
BibTeX
@article{Wong2026,
author = {Wong, U Sin and Guo, Dajiang},
title = {Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2487},
doi = {10.3390/cancers18152487}
}
EUVIMED